Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage
This is Cheryl Nickerson of the Biodesign Institute at Arizona State University. Credit: Nick Meek
On July 8, at approximately 11:26 a.m. EDT, the space shuttle Atlantis will streak skyward from the Kennedy Space Center's launch pad 39A, for one last mission. While the STS-135 flight marks the end of the space shuttle's glory days, its final trip may open a new era of research into infectious diseases, thanks to space bound experiments conducted by Dr's. Cheryl Nickerson, and Roy Curtiss III, along with their colleagues at Arizona State University's Biodesign Institute.
Nickerson, a microbiologist and authority on infectious pathogens, has been using spaceflight or spaceflight analogues since 1998 as an exploratory platform for investigating the processes of infection. Her provocative approach to microbial research has already paid rich dividends. In earlier experimental missions, Nickerson's team demonstrated that conditions of microgravity present aboard the space shuttle have the potential to increase the disease-causing capacity or virulence of microbes like Salmonellaa major causative agent of food-borne illness.
Further, her research demonstrated that spaceflight globally altered gene expression in Salmonella and other pathogens in critical ways that were not observed during culture on Earth, and were governed by a master switch regulating this response. "Our earlier work showed the potential for spaceflight to provide novel insight into the mechanisms of microbial virulence that may lead to innovations in infectious disease control here on Earth," she said.
Curtiss, director of the Biodesign Institute's Center for Infectious Diseases and Vaccinology, has engineered an experimental vaccine strain, which will fly aboard Atlantis on its journey to the International Space Station Laboratory. By removing the disease-causing components of Salmonella and incorporating a key protective antigen from Streptococcus pneumoniae, Curtiss has produced a powerful oral vaccine against pneumonia, that has shown promise in phase 1 human clinical trials. The ability of spaceflight to enhance the efficacy of this recombinant attenuated Salmonella vaccine, or RASV, will be the focus of the Atlantis mission.
Current experiments aboard STS-135 will build on decades of earlier research by Nickerson and Curtiss, in attempts to improve the effectiveness of RASVs. These vaccines exploit Salmonella's renowned infectious capacity in order to produce a strong, system-wide immune response. In addition to the defensive response to Salmonella, the vaccine recipient also marshals an immune response to secondary disease antigens studded on the pathogen's surface membranein this case, antigens to pneumococcus, the causative agent of pneumonia.
"Many breakthroughs in life sciences research and translational advancements to the healthcare setting, have been achieved through studying the response of biological systems to extreme environments," Nickerson says. The extreme environment in the present study is the reduced gravity present during spaceflight, which alters a fundamental physical property encountered by living cells, known as fluid shear.
Fluid shear refers to the physical forces exerted on cells by the extracellular liquids surrounding them. Previous experiments by Nickerson aboard the space shuttles Endeavour and Atlantis showed that changes in fluid shear due to microgravity induced important cellular responses in pathogens, including unique alterations in gene expression and virulence.
Nickerson notes that the responses of pathogenic cells to microgravity may be closely correlated with their behavior during infection here on earth, where the effects of low fluid shear environments present in the body are believed to contribute to virulence. Such pathogen responses, however, may often evade detection in conventional in vitro experiments on earth, where gravity may be masking this effect. In the current study, this approach is being applied to Salmonella vaccines. Because RASVs can be produced against a wide variety of human and animal pathogens, the outcome of this research could influence the development of vaccines against many other diseases in addition to pneumonia
Unlike existing anti-pneumococcal vaccines, Curtiss' RASV may be given orally and acts to stimulate mucosal, humoral and cellular immunity, offering enhanced protection. Diseases due to Streptococcus pneumoniae include community-acquired pneumonia, otitis media, meningitis, and bacteremia, and are responsible for some 10 million fatalities per year. Pneumonia poses a particular threat to newborns and the elderly, who may fail to mount an effective immune response after receiving current anti-pneumococcal vaccines.
The current experiments planned for Atlantis' final mission represent an interesting twist in Nickerson's research into microbial virulence and modes of infection, which she has pursued with longtime collaborator Mark Ott, a senior microbiologist at the Johnson Space Center and a Co-Investigator on the RASV flight experiment. Again, the pathogen of choice is Salmonella, but here, the invader has been genetically re-engineered to protect from infectious disease, rather than to cause it. The outcome of this research has the potential for better protecting astronauts, who are keenly vulnerable to infection during spaceflight, as well as to help engineer better therapeutics for infectious diseases on earth.
Specially designed growth chambers containing the vaccine strain will travel with Shuttle Atlantis to the International Space Station. During spaceflight, crewmembers will activate the samples, while simultaneously, an earthbound sample will be grown under otherwise identical conditions. The spaceflight cultured RASV strain, upon its return, will be evaluated against the control sample and analyzed for its ability to protect against pneumococcal infection.
Nickerson and Curtiss hope that results from the RASV spaceflight study will offer important clues for producing a more protective anti-pneumococcal immune response, while limiting undesired side effects.
Although the space shuttle program now enters retirement, space-based research into infectious diseases and vaccinology will continue, thanks to the newly signed Space Act Agreement between the National Laboratory Office and the Biodesign Institute, which will grant routine access to the ISS for continuing research. Nickerson is enthusiastic about spaceflight research and the significant clinical potential for the current study:
"It is incredibly exciting to me that we have the opportunity to utilize spaceflight as a unique research and development platform for novel applications with potential to help fight a globally devastating disease."
Provided by Arizona State University
- Microscopic 'astronauts' to go back in orbit Mar 10, 2008 | not rated yet | 0
- Out of this world: New study investigates infection of human cells in space Apr 02, 2010 | not rated yet | 0
- Spacebound bacteria inspire earthbound remedies Mar 21, 2011 | not rated yet | 0
- Microscopic passengers to hitch ride on space shuttle Aug 24, 2006 | not rated yet | 0
- New salmonella-based 'clean vaccines' aid the fight against infectious disease Jun 29, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
Nearly 20 percent of kidneys that are recovered from deceased donors in the U.S. are refused for transplant due to factors ranging from scarring in small blood vessels of the kidney's filtering units to the organ going too ...
Medical research 7 hours ago | 5 / 5 (1) | 0 |
Discovery of circadian clock in mice hair reveals period of time when damage from radiotherapy can be quickly repaired
Discovering that mouse hair has a circadian clock - a 24-hour cycle of growth followed by restorative repair - researchers suspect that hair loss in humans from toxic cancer radiotherapy and chemotherapy ...
Medical research 7 hours ago | 5 / 5 (2) | 1 |
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
Medical research 8 hours ago | 5 / 5 (4) | 2 |
New research from the University of Southampton has shown that blind and visually impaired people have the potential to use echolocation, similar to that used by bats and dolphins, to determine the location of an object.
Medical research 11 hours ago | not rated yet | 1 |
A novel vaccine study from South Dakota State University (SDSU) will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference ...
Medical research 11 hours ago | not rated yet | 0
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
8 hours ago | 4.8 / 5 (8) | 1 |
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
8 hours ago | 5 / 5 (3) | 0 |
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
6 hours ago | 3.4 / 5 (8) | 0 |
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
5 hours ago | not rated yet | 0 |
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...
5 hours ago | not rated yet | 0 |
University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...
6 hours ago | 5 / 5 (1) | 0 |